Materials & Resources » Chemicals | Porton Fine Chemicals Ltd.

Porton Fine Chemicals Ltd. | Mutual Funds

Mutual Funds that own Porton Fine Chemicals Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
lnvesco Great Wall Domestic Demand Growth II Fund
4,620,931
1.5%
1,780,704
2.49%
12/31/2017
Invesco Great Wall Domestic Demand Growth Fund
2,351,164
0.76%
699,400
2.4%
12/31/2017
Hong Yang Fund
1,761,189
0.56%
1,761,189
0.87%
12/31/2016
1,225,471
0.4%
1,225,471
0.38%
12/31/2017
Invesco Great Wall Small & Mid Cap Equity Fund
352,500
0.11%
85,300
2.41%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
321,250
0.1%
0
0%
07/31/2018
126,827
0.04%
10,300
0.13%
12/31/2017
79,000
0.03%
79,000
0.28%
12/31/2017
4,800
0%
-400
0.06%
12/31/2017
3,400
0%
-600
0.06%
12/31/2017

About Porton Fine Chemicals

View Profile
Address
Fangzheng Avenue
Chongqing Chongqing 400714
China
Employees -
Website http://www.porton.cn
Updated 07/08/2019
Porton Pharma Solutions Ltd. engages in the research and development and manufacture of pharmaceutical products and active pharmaceutical ingredients. It offers anti-viral, anti-diabetic, anti-hypertensive, anti-cancer, analgesic, hypolipidemic, and antibacterial drug treatment. The company was founded on July 7, 2005 and is headquartered in Chongqing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.